Insights into Structural Determinants of Cholesterol Sensitivity of Kir Channels

Cholesterol Regulation of Ion Channels and Receptors

Volumn , Issue , 2012, Pages 45-67

  Rosenhouse Dantsker, Avia ^a   Levitan, Irena ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cholesterol in Kir2, cholesterol sensitivity belt and channel gating; Cholesterol regulation, membrane cholesterol level as ion channel regulators; Cholesterol induced suppression of Kir2, and physiological impact; Specific sterol protein in Kir channel regulation; Structural determinants of KIR cholesterol sensitivity, in cholesterol protein

Indexed keywords

EID: 84885664725     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118342312.ch3     Document Type: Chapter

References (79)

1. Beuckelmann DJ, Nabauer M, Erdmann E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73: 379-385.
2. Bichet D, Haass FA, Jan LY. Merging functional studies with structures of inward-rectifier K+ channels. Nat Rev Neurosci 2003;4:957-967.
3. Bittman R, Blau L. The phospholipid-cholesterol interaction. Kinetics of water permeability in liposomes. Biochemistry 1972;11:4821-4839.
4. Bradley KK, Jaggar JH, Bonev AD, Heppner TJ, Flynn ERM, Nelson MT, Horowitz B. Kir2.1 encodes the inward rectifier potassium channel in rat arterial smooth muscle cells. J Physiol 1999;515(3):639-651.
5. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC. High-resolution crystal structure of an engineered human ß2-adrenergic G protein-coupled receptor. Science 2007;318:1258-1265.
6. Covey DF. ent-Steroids: novel tools for studies of signaling pathways. Steroids 2009; 74(7):577-585.
7. D'Avanzo N, Hyrc K, Enkvetchakul D, Covey DF, Nichols CG. Enantioselective proteinsterol interactions mediate regulation of both prokaryotic and eukaryotic inward rectifier K+ channels by cholesterol. PLoS ONE 2011;6(4):e19393.
8. de Smet BJ, van der Zande J, van der Helm YJ, Kuntz RE, Borst C, Post MJ. The atherosclerotic Yucatan animal model to study the arterial response after balloon angioplasty: the natural history of remodeling. Cardiovasc Res 1998;39:224-232.
9. Delling M, Wischmeyer E, Dityatev A, Sytnyk V, Veh RW, Karschin A, Schachner M. The neural cell adhesion molecule regulates cell-surface delivery of G-protein-activated inwardly rectifying potassium channels via lipid rafts. J Neurosci 2002;22(16): 7154-7164.
10. Demel RA, Bruckdorfer KR, van Deenen LL. Structural requirements of sterols for the interaction with lecithin at the air-water interface. Biochim Biophys Acta 1972;255: 311-320.
11. Enkvetchakul D, Bhattacharyya J, Jeliazkova I, Groesbeck DK, Cukras CA, Nichols CG. Functional characterization of a prokaryotic Kir channel. J Biol Chem 2004;279(45): 47076-47080.
12. Enkvetchakul D, Jeliazkova I, Bhattacharyya J, Nichols CG. Control of inward rectifier K channel activity by lipid tethering of cytoplasmic domains. J Gen Physiol 2007;130(3):329-334.
13. Enkvetchakul D, Jeliazkova I, Nichols CG. Direct modulation of Kir channel gating by membrane phosphatidylinositol 4,5-bisphosphate. J Biol Chem 2005;280(43): 35785-35788.
14. Epand RM. Cholesterol and the interaction of proteins with membrane domains. Prog Lipid Res 2006;45(4):279-294.
15. Epshtein Y, Chopra AP, Rosenhouse-Dantsker A, Kowalsky GB, Logothetis DE, Levitan I. Identification of a C-terminus domain critical for the sensitivity of Kir2.1 channels to cholesterol. Proc Natl Acad Sci USA 2009;106:8055-8060.
16. Fang Y, Mohler ER III, Hsieh E, Osman H, Hashemi SM, Davies PF, Rothblat GH, Wilensky RL, Levitan I. Hypercholesterolemia suppresses inwardly rectifying K+ channels in aortic endothelium in vitro and in vivo. Circ Res 2006;98(8):1064-1071.
17. Fang Y, Romanenko VG, Davies PF, Levitan I. Flow sensitivity of inwardly-rectifying K channels in human aortic endothelium. In: 3d IASTED International Conference on Biomechanics. Benidorm, Spain: ACTA Press; 2005a. pp. 163-167.
18. Fang Y, Schram G, Romanenko VG, Shi C, Conti L, Vandenberg CA, Davies PF, Nattel S, Levitan I. Functional expression of Kir2.x in human aortic endothelial cells: the dominant role of Kir2.2. Am J Physiol Cell Physiol 2005b;289(5):C1134-C1144.
19. Filosa JA, Bonev AD, Straub SV, Meredith AL, Wilkerson MK, Aldrich RW, Nelson MT. Local potassium signaling couples neuronal activity to vasodilation in the brain. Nat Neurosci 2006;9(11):1397.
20. Forsyth SE, Hoger A, Hoger JH. Molecular cloning and expression of a bovine endothelial inward rectifier potassium channel. FEBS Lett 1997;409(2):277-282.
21. Fox PL, DiCorleto PE. Modified low density lipoproteins suppress production of a plateletderived growth factor-like protein by cultured endothelial cells. Proc Natl Acad Sci USA 1986;83:4774-4778.
22. Garneau L, Klein H, Sauve R. Contribution of cytosolic cysteine residues to the gating properties of the Kir2.1 inward rectifier. Biophys J 2003;84:3717-3729.
23. Gimpl G, Burger K, Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry 1997;36:10959-10974.
24. Gupta S, Bavro VN, Chance MR. Conformational changes during the gating of a potassium channel revealed by structural mass spectrometry. Structure 2010;18:839-846.
25. Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola VP, Chien EYT, Velasquez J, Kuhn P, Stevens RC. A specific cholesterol binding site is established by the 2.8 °A structure of the human ß-adrenergic receptor. Structure 2008;16:897-905.
26. Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y. Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 2010;90(1):291-366.
27. Hibino H, Kurachi Y. Distinct detergent-resistant membrane microdomains (lipid rafts) respectively harvest K+ and water transport systems in brain astroglia. Eur J Neurosci 2007;26(9):2539-2555.
28. Inanobe A, Matsuura T, Nakagawa A, Kurachi Y. Structural diversity in the cytoplasmic region of G protein-gated inward rectifier K+ channels. Channels 2007;1:39-45.
29. Ishii K, Yamagishi T, Taira N. Cloning and functional expression of a cardiac inward rectifier K+ channel. FEBS Lett 1994;338(1):107.
30. Jackson WF. Silent inward rectifier K+ channels in hypercholesterolemia. Circ Res 2006;98(8):982-984.
31. Jones OT, McNamee MG. Annular and Nonannular Binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry 1998;27:2364-2374.
32. Kamouchi M, Van Den Bremt K, Eggermont J, Droogmans G, Nilius B. Modulation of inwardly rectifying potassium channels in cultured bovine pulmonary artery endothelial cells. J Physiol 1997;504:545-556.
33. Karkanis T, Li S, Pickering JG, Sims SM. Plasticity of KIR channels in human smooth muscle cells from internal thoracic artery. Am J Physiol Heart Circ Physiol 2003;284(6):H2325-H2334.
34. Kim JA, Maxwell K, Hajjar DP, Berliner JA. b-VLDL increases endothelial cell plasma membrane cholesterol. J Lipid Res 1991;32:1125-1131.
35. Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S, Vandenberg CA. International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev 2005;57(4):509-526.
36. Kuo A, Domene C, Johnson LN, Doyle DA, V́enien-Bryan C. Two different conformational states of the KirBac3.1 potassium channel revealed by electron crystallography. Structure 2005;13:1463-1472.
37. Kuo A, Gulbis JM, Antcliff JF, Rahman T, Lowe ED, Zimmer J, Cuthbertson J, Ashcroft FM, Ezaki T, Doyle DA. Crystal structure of the potassium channel KirBac1.1 in the closed state. Science 2003;300(5627):1922-1926.
38. Levitan I. Cholesterol and Kir channels. IUBMB Life 2009;61:781-790.
39. Levitan I, Fang Y, Rosenhouse-Dantsker A, Romanenko V. Cholesterol and ion channels. Subcell Biochem 2010;51:509-549.
40. Li H, Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 1998;139:4991-4997.
41. Lopes CM, Zhang H, Rohacs T, Jin T, Yang J, Logothetis DE. Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies. Neuron 2002;34:933-944.
42. Maguy A, Hebert TE, Nattel S. Involvement of lipid rafts and caveolae in cardiac ion channel function. Cardiovasc Res 2006;69(4):798.
43. Martens JR, O'Connell K, Tamkun M. Targeting of ion channels to membrane microdomains: localization of KV channels to lipid rafts. Trends Pharmacol Sci 2004;25:16-21.
44. Melnyk P, Zhang L, Shrier A, Nattel S. Differential distribution of Kir2.1 and Kir2.3 subunits in canine atrium and ventricle. Am J Physiol Heart Circ Physiol 2002;283(3):H1123-H1133.
45. Miake J, Marban E, Nuss HB. Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J Clin Invest 2003;111:1529-1536.
46. Mohler III ER, Fang Y, Gusic Shaffer R, Moore J, Wilensky RL, Parmacek M, Levitan I. Hypercholesterolemia suppresses Kir channels in porcine bone marrow progenitor cells in vivo. Biochem Biophys Res Commun 2007;358(1):317-324.
47. Murari R, Murari MP, Baumann WJ. Sterol orientations in phosphatidylcholine liposomes as determined by deuterium NMR. Biochemistry 1986;25:1062-1067.
48. Nichols C, Lopatin A. Inward rectifier potassium channels. Annu Rev Physiol 1997;59: 171-191.
49. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 2001;81:1415-1459.
50. Nishida M, Cadene M, Chait BT, MacKinnon R. Crystal structure of a Kir3.1-prokaryotic Kir channel chimera. EMBO J 2007;26:4005-4015.
51. Olesen S-P, Clapham DE, Davies PF. Hemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 1988;331:168-170.
52. Pegan S, Arrabit C, Zhou W, Kwiatkowski W, Collins A, Slesinger PA, Choe S. Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification. Nat Neurosci 2005;8:279-287.
53. Piao L, Li J, McLerie M, Lopatin A. Transgenic upregulation of IK1 in the mouse heart is proarrhythmic. Basic Res Cardiol 2007;102:416-428.
54. Picazo-Juarez G, Romero-Suarez S, Nieto-Posadas A, Llorente I, Jara-Oseguera A, Briggs M, McIntosh TJ, Simon SA, Ladron-de-Guevara E, Islas LD, Rosenbaum T. Identification of a binding motif in the S5 helix that confers cholesterol-sensitivity to TRPV1. J Biol Chem 2011;286(28):24966-24976.
55. Pike LJ. Rafts defined: a report on the Keystone symposium on lipid rafts and cell function. J Lipid Res 2006;47(7):1597-1598.
56. Plaster NM, Tawil R, Tristani-Firouzi M, Canun S, Bendahhou S, Tsunoda A, Donaldson MR, Iannaccone ST, Brunt E, Barohn R, Clark J, Deymeer F, George ALJ, Fish FA, Hahn A, Nitu A, Ozdemir C, Serdaroglu P, Subramony SH, Wolfe G, Fu YH, Ptacek LJ. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001;105:511-519.
57. Radhakrishnan A, Sun L-P, Kwon HJ, Brown MS, Goldstein JL. Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain. Mol Cell 2004;15(2):259.
58. Rankin SE, Addona GH, Kloczewiak MA, Bugge B, Miller KW. The cholesterol dependence of activation and fast desensitization of the nicotinic acetylcholine receptor. Biophys J 1997;73:2446-2455.
59. Ricci R, Sumara G, Sumara I, Rozenberg I, Kurrer M, Akhmedov A, Hersberger M, Eriksson U, Eberli FR, Becher B, Boren J, Chen M, Cybulsky MI, Moore KJ, Freeman MW, Wagner EF, Matter CM, Luscher TF. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 2004;306(5701):1558-1561.
60. Rivers RJ, Hein TW, Zhang C, Kuo L. Activation of barium-sensitive inward rectifier potassium channels mediates remote dilation of coronary arterioles. Circulation 2001;104(15):1749-1753.
61. Romanenko VG, Fang Y, Byfield F, Travis AJ, Vandenberg CA, Rothblat GH, Levitan I. Cholesterol sensitivity and lipid raft targeting of Kir2.1 channels. Biophys J 2004;87:3850-3861.
62. Romanenko VG, Rothblat GH, Levitan I. Modulation of endothelial inward rectifier K+ current by optical isomers of cholesterol. Biophys J 2002;83:3211-3222.
63. Rosenhouse-Dantsker A, Leal-Pinto E, Logothetis DE, Levitan I. Comparative analysis of cholesterol sensitivity of Kir channels: role of the CD loop. Channels 2010;4:63-66.
64. Rosenhouse-Dantsker A, Logothetis DE, Levitan I. Cholesterol sensitivity of KIR2.1 is controlled by a belt of residues around the cytosolic pore. Biophys J 2011;100(2):381.
65. Sampson LJ, Davies LM, Barrett-Jolley R, Standen NB, Dart C. Angiotensin II-activated protein kinase C targets caveolae to inhibit aortic ATP-sensitive potassium channels. Cardiovasc Res 2007;76(1):61-70.
66. Sampson LJ, Hayabuchi Y, Standen NB, Dart C. Caveolae localize protein kinase A signaling to arterial ATP-sensitive potassium channels. Circ Res 2004;95(10):1012-1018.
67. Simmonds AC, East JM, Jones OT, Rooney EK, McWhirter J, Lee AG. Annular and nonannular binding sites on the (Ca2+ + Mg2+)-ATPase. Biochim Biophys Acta 1982;693:398-406.
68. Singh DK, Rosenhouse-Dantsker A, Nichols CG, Enkvetchakul D, Levitan I. Direct regulation of prokaryotic Kir channel by cholesterol. J Biol Chem 2009;284(44): 30727-30736.
69. Sunshine C, McNamee MG. Lipid modulation of nicotinic acetylcholine receptor function: the role of membrane lipid composition and fluidity. Biochim Biophys Acta 1994;1191:59-64.
70. Swinkels DW, Demacker PN. Comparative studies on the low density lipoprotein subfractions from pig and man. Comp Biochem Physiol B 1988;90:297-300.
71. Thomas J, Epshtein Y, Chopra A, Ordog B, Ghassemi M, Christman JW, Nattel S, Cook JL, Levitan I. Anthrax lethal factor activates K+ channels to induce IL-1ß secretion in macrophages. J Immunol 2011;186:5236-5243.
72. Tikku S, Epshtein Y, Collins H, Travis AJ, Rothblat GH, Levitan I. Relationship between Kir2.1/Kir2.3 activity and their distribution between cholesterol-rich and cholesterolpoor membrane domains. Am J Physiol Cell Physiol 2007;293:C440-C450.
73. Tristani-Firouzi M, Jensen JL, Donaldson MR, Sansone V, Meola G, Hahn A, Bendahhou S, Kwiecinski H, Fidzianska A, Plaster N, Fu Y-H, Ptacek LJ, Tawil R. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002;110(3):381-388.
74. Vicente R, Escalada A, Coma M, Fuster G, Sanchez-Tillo E, Lopez-Iglesias C, Soler C, Solsona C, Celada A, Felipe A. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J Biol Chem 2003;278(47):46307-46320.
75. Vivaudou M, Chan KW, Sui JL, Jan LY, Reuveny E, Logothetis DE. Probing the Gprotein regulation of GIRK1 and GIRK4, the two subunits of the KACh channel, using functional homomeric mutants. J Biol Chem 1997;272:31553-31560.
76. Wible BA, De Biasi M, Majumder K, Taglialatela M, Brown AM. Cloning and functional expression of an inwardly rectifying K+ channel from human atrium. Circ Res 1995;76(3):343-350.
77. Xu X, London E. The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 2000;39:843-849.
78. Zaritsky JJ, Eckman DM, Wellman GC, Nelson MT, Schwarz TL. Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K+ current in K+-mediated vasodilation. Circ Res 2000;87(2):160-166.
79. Zhang H, He C, Yan X, Mirshahi T, Logothetis DE. Activation of inwardly rectifying K+ channels by distinct Ptdlns(4,5)P2 interactions. Nat Cell Biol 1999;1:183-188.